印度最高法院禁止未经证实的自闭症干细胞疗法,称其为不道德和不安全的临床试验。 India's Supreme Court bans unproven stem cell therapy for autism, calling it unethical and unsafe outside clinical trials.

印度最高法院禁止在经批准的临床试验之外使用干细胞疗法治疗自闭症谱系障碍,称其不道德,并可能因缺乏科学证据而造成渎职。 The Supreme Court of India has banned the use of stem cell therapy for autism spectrum disorder outside approved clinical trials, calling it unethical and potentially malpractice due to lack of scientific evidence. 法院强调,此类治疗未经医学验证,并警告诊所不得利用未经证实的疗法剥削弱势家庭。 The court emphasized that such treatments are not medically validated and warned against clinics exploiting vulnerable families with unproven therapies. 只有具有科学意图的研究试验才允许进行,并指示政府制定明确的条例以防止伤害和确保病人的安全。 Only research-based trials with scientific intent are permitted, and the government was directed to establish clear regulations to prevent harm and ensure patient safety.